This program addresses the massive problem of iatrogenic injury and death, the inadequacy of the law’s conventional response, and several of the more innovative approaches the law might be taking in the future to raise the level of patient safety. Those more innovative approaches will be more regulatory than litigative.
Three areas to be discussed are new incentives for investment in safety, error reporting, and engaged surveillance.
Learning Objectives:
• Acquire a more complete picture of the nature and extent of the problem of iatrogenic harm.
• Understand the limited efficacy of malpractice liability in encouraging prevention of harm.
• Learn about new incentives (existing and proposed) to create a business case for patient safety.
• Learn about failings of error reporting regimes.
• Learn about engaged surveillance.
During this course, we will go over your rights under the Freedom of Information Act (FOIA) and Priv...
As the largest purchaser of goods and services in the world, the United States Government requires f...
This program is geared towards lawyers, experts, commercial property owners, and others in the envir...
This program provides attorneys with a foundational understanding of derivatives and their role in m...
This course examines the latest legal and compliance developments in the artificial intelligence (AI...
Lawyers regularly communicate with clients who are angry, overwhelmed, frightened, unrealistic, or d...
This course on trade secrets litigation provides real-world best practices through all key stages of...
Class action litigation continues to evolve rapidly in response to an innovative plaintiffs’ b...
Have you felt overwhelmed by the amount of technology available to family lawyers? We'll get to know...
This one-hour CLE program examines the impact of implicit and systemic bias within the legal profess...